Research
Hormonal
Long-acting amylin analogues have beneficial effects on body weight in obesity.
Long-acting amylin analogues may be considered as a treatment option for obesity.
StrongSupportsmedium confidence
Both preclinical and early-stage clinical studies investigating long-acting amylin receptor analogues demonstrate beneficial effects on body weight in obesity.
Why this rating
Based on the mention of preclinical and early-stage clinical studies.
Source
Long-acting amylin analogues for the management of obesity
David S. Mathiesen et al. · Current Opinion in Endocrinology Diabetes and Obesity · 2022
reviewCited 37×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →